Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07463833 · ClinicalTrials.gov registry record · NA

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
207
Enrollment target

NCT07463833 is a NA study that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 207 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07463833, a NA study, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care. The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.

Interventions

  • DEVICE The Artificial Intelligence (AI)/ Machine Learning (ML) contribution to treatment planning

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2026-06-22
Est. Completion 2027-07
Phase NA

What the Registry Record Tells You About NCT07463833

The ClinicalTrials.gov registry entry for NCT07463833 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which The Artificial Intelligence (AI)/ Machine Learning (ML) contribution to treatment planning is the first listed.

NCT07463833 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07463833 about?

NCT07463833 is a clinical study titled "Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology". This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care. The system highl...

What is the current status of trial NCT07463833?

This trial is currently recruiting. It is a NA study. The enrollment target is 207 participants. The study started on 2026-06-22. Estimated completion is 2027-07.

What interventions are being tested in trial NCT07463833?

The interventions under investigation include: The Artificial Intelligence (AI)/ Machine Learning (ML) contribution to treatment planning (DEVICE).

Who is sponsoring clinical trial NCT07463833?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.